Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Feb 02, 2023 10:15pm
172 Views
Post# 35263903

RE:Baxter vs Seto and Co..

RE:Baxter vs Seto and Co..

Despite words of encouragement from your new cheerleader BSW ( a self admitted opportunist that preys on people's fears - see fall 2021) 
... there are several holes in your thesis 

ON top of the $6.5 M Baxter purchased dont forget the millions more in notes that were purchased just 2 months ago. 

And they are spending more big $ on commercialization preparations including Prism HP approvals ( unless you think Spectral is lying in its NR?) 

On top of that, Baxter was  fully aware of the latest rate of enrolment ( you know the 1 enrollee in Dec on which you are basing your whole 180 degree shift in sentiment and or latest FUD programme). 

Also aware of the meager enrolment in the fall, was none other than the FA80 who were apparently goodwiddit - so much so that they  coughed up another +\- $5m. As were key members of the BOD who coughed up $ AND who were/are also apparently fine with the two key Mgrs - I wonder why? What more does Baxter and FA80 and the BOD know that a small group of retailers do not? My gut is that one " disillusioned" paid bad guy with several handles and an agenda, knows but is not at liberty to say. 

Baxter wanted and got RoFR on distribution rights for PMX ( the only hope on the horizon to effectively treat Sepsis since oXiris doesn't work that well ) ... and will pay more to seal up access to a multi-billion $ opportunity ( albeit 2 more redacted amounts that I would guess adds up to more than 8 figures.) 

At that point,  Spectrals job is done... and it's Baxters move if they want ALL the profits and control in NA. Not to mention worldwide control of the critical FDA approved companion diagnostic ( the keys to the car) owned outright by Spectral. 

Good thing that the Dialco asset was carved out first - makes it easier to effect a share purchase without a mixing of the distinct assets owned proportionately by all shareholders. When you sell the house you might include the drapes but typically not the grand piano, dog, and collection of rare whiskies  


MM

<< Previous
Bullboard Posts
Next >>